Vimarsana
Biggest News Aggregation in the World

Page 21 - Double Blind Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Double Blind Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Double Blind Study Today - Breaking & Trending Today

Dupilumab for EoE: How Is it Improving Treatment? - Vimarsana News

Dupilumab for EoE: How Is it Improving Treatment?

The drug was a boon for many patients, mainly those with moderate to severe disease, but cost and insurance approvals posed challenges.

FDA Approves First Cellular Therapy for Metastatic Melanoma - Vimarsana News

FDA Approves First Cellular Therapy for Metastatic Melanoma

Lifileucel is the first cellular therapy to be approved to treat patients with unresectable or metastatic melanoma.

Nonablative RF Treatment Effective in Adults With Acne - Vimarsana News

Nonablative RF Treatment Effective in Adults With Acne

The study is thought to be the first comprehensive analysis to evaluate NMRF as a treatment for acne, according to the authors.

Salt Substitute Reduces Risk for New Hypertension - Vimarsana News

Salt Substitute Reduces Risk for New Hypertension

Among older adults with normal blood pressure, replacing table salt with salt substitute reduced the incidence of hypertension vs a usual salt group, in the DECIDE-Salt trial.

Benefit of Thrombolysis With Thrombectomy Only Given Early? - Vimarsana News

Benefit of Thrombolysis With Thrombectomy Only Given Early?

In patients presenting at thrombectomy-capable stroke centers, the benefit associated with thrombolysis before thrombectomy was time dependent, new data suggested.